Pulse Oximeters Market Size, Share and Trends 2026 to 2035

Revenue, 2025

USD 2.72 Bn

Forecast Year, 2035

USD 6.57 Bn

CAGR, 2026 - 2035

9.22%

Report Coverage

Global

What is the Pulse Oximeters Market Size?

The global pulse oximeters market size was estimated at USD 2.72 billion in 2025 and is anticipated to reach around USD 6.57 billion by 2035, expanding at a CAGR of 9.22% from 2026 to 2035. The growing demand in the pulse oximeters market can be attributed to increasing instances of respiratory illnesses and an increasingly geriatric population which requires regular monitoring of blood oxygen levels.

Pulse Oximeters Market Key Takeaways

• North America has held the maximum market share of 49% in 2025.
• By end-use, the hospitals segment had the major market in 2025.
• By end-use, the home healthcare segment is expected to expand at the fastest CAGR over the projected period.
• By product type, the tabletop oximeters held the largest market share of the market in 2025.

Market Overview

According to the data released in January 2025, years of research have shown that pulse oximeters yield less accurate readings for individuals with darker skin tones, and now the US Food and Drug Administration is proposing guidance to help make these devices more reliable and less biased. People with darker skin are 32% more likely to have pulse oximeter readings that overestimate oxygen levels.

The FDA announced that it has published draft guidance for manufacturers of pulse oximeters that offers recommendations for the clinical testing and labeling of these electronic medical devices. This draft guidance is aligned with the FDA's broader commitment to improve the accuracy of pulse oximeters for people with darker skin tones and facilitate the development of high-quality and safe medical devices.

What Is a Pulse Oximeter?

A pulse oximeter is a device that is usually clipped on a fingertip and utilizes light beams to measure a person's blood oxygen level and their pulse rate. It is used in clinics, hospitals, and homes because it works fast and does not break the skin. The demand for pulse oximeters is mainly driven by healthcare monitoring needs rather than casual use. As oxygen saturation monitoring is essential in emergency medicine, anesthesia, post-op care, and respiratory treatment, hospitals, clinics, and ambulatory care centers maintain continuous demand.

Impact of AI on the market

Pulse oximetry is a non-invasive means of monitoring blood oxygen saturation, which provides vital information for the respiratory function of patients. Artificial intelligence has revolutionized the study of PPG signals and then provided very high accuracy and reliability to the process. AI-enhanced PPG analysis would improve the clinical outcome for patients in anesthesia, intensive care, peri-operative medicine, and other similar settings. This is usually to offer more accurate measurements under difficult conditions like motion or very poor perfusion. It gets better at handling variability and noise in PPG signals bringing the added potential benefit of robust, non-invasive monitoring of blood oxygen levels under different clinical scenarios. Innovations in AI techniques will overcome present limitations by providing solutions for such conditions for real-time monitoring in various environmental and physiological conditions.

Pulse Oximeters Market Growth Factors

• Numerous benefits offered by pulse oximeters such as portability, connectivity, and compact size are triggering the market growth across the world. Furthermore, the increasing demand for consistent vital stats monitoring and rising emphasis on patient safety during anesthesia is projected to drive the growth of the pulse oximeter market. Moreover, pulse oximeter market growth is mainly driven by the growing adoption of oximeters in critical care, childbirth, surgery, neonatal, anesthesia, & pediatric care and technological advancements in oximeters. However, an increase in healthcare expenditure in the developing countries and high demand for proactive monitoring are anticipated to create new opportunities for market players in the near future. Nevertheless, the dearth of awareness in developing regions is expected to hinder the market growth.
• Escalating implementation of wireless pulse oximeters by home consumers and clinicians is projected to spur the sale of pulse oximeters worldwide. Portability offered by wireless pulse oximeters is propelling growth of finger-top and wrist pulse oximeters, specifically in home care situations. Masimo introduced wireless pulse oximeter named, Masimo Rad - 5, that achieved enormous popularity due to its superior wireless features.
• Home care captures the imagination of people, primarily for convenience and cost-related reasons, mainly in areas where repayment policies are fragile; subsidize profoundly to the growth for a global pulse oximeter market. In addition, the demand for remote monitoring is seeing a hasty rise as continuous monitoring is an expensive task, boosting the growth of pulse oximeter market as spot-checking via fingertip alternatives and handheld oximeters. This may help to reduce cost on readmission costs that are quite usually incurred by patients of COPD.
• In addition, the existing apprehension over the proliferation of coronavirus is also foreseen to have a substantial influence on the growth of global pulse oximeters market across the world. As a consequence of the current pandemic, the medical device industry has been under tremendous pressure to deliver new products. With coronavirus infections propagating worldwide, the apprehension regarding a shortage of crucial life-saving devices and additional indispensable medical supplies in order to inhibit the spread of this pandemic and deliver prime care to the infected also widen.

Market Scope

Market Dynamics

Drivers

Rising cases of respiratory issues

The cases of asthma, chronic obstructive pulmonary disease and pneumonia are respiratory issues that are rising all over the world. The low concertation of oxygen levels in patients with these conditions require monitoring of blood oxygen levels. The pulse oximeters are a non-invasive device that help measure oxygen saturation. The rising levels of pollutions, rising geriatric population and changing lifestyle have increased the number of cases with respiratory issues.

• According to the data published by the World Health Organization (WHO) in November 2024, Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, causing 3.5 million deaths in 2021, approximately 5% of all global deaths. Nearly 90% of COPD deaths in those under 70 years of age occur in low- and middle-income countries (LMIC).

Restraint

Government Regulations

The governments all over the world are tightening rules and regulation related to sale of medical devices like oximeters directly to the consumers without prescriptions. This will make it difficult for people to get the device as a precautionary measure without medical consultations. The stricter rules have also been enforced due to concerns about accuracy of these oximeters and how reliable the information could be.

Opportunity

Key players interest in developing economies

The major players of the oximeter market are looking to explore the untapped potential for growth in the emerging economies. The governments in countries like India and China are on the look out for opportunities to invest in the healthcare sector especially in modernizing their existing infrastructure. Such countries are becoming hubs of manufacturing for healthcare and pharmaceutical products. The region of Asia Pacific promises potential of growth for the pulse oximeters market.

• In December 2024, Movano Health announced the 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the pulse oximeter in its EvieMED Ring. The clearance enables Movano Health to pursue multi-billion-dollar business opportunities for health monitoring solutions needed for applications such as clinical trials, post-clinical trial management, and remote patient monitoring.
• In December 2024, the FDA granted 510(k) clearance for Nonin Medical's TruO2 OTC fingertip pulse oximeter, a medical-grade device designed for accurate blood oxygen readings across all skin tones. The US Food and Drug Administration (FDA) has granted Nonin Medical 510(k) clearance for its over-the-counter fingertip pulse oximeter, the TruO2 OTC, designed for accuracy across all skin tones.

Segment Insights

Product Type Insights

Which Product Type Segment Dominated the Pulse Oximeters Market in 2025?

The tabletop/bed side pulse oximeter segment dominated the market in 2025, driven by its widespread use in healthcare settings including hospitals, emergency departments, clinics, surgical theaters, intensive care units, and post-anesthesia care units. The reliability and efficient functioning of tabletop oximeters are important aspects in making it a popular choice. An emphasis on enhancing diagnostic accuracy and accessibility is boosting the demand.

The fingertip oximeters segment is expected to grow at the fastest rate during the forecast period, due to their affordability, compact design, and ease of use, making them the popular choice for home care. Growing demand for remote health monitoring especially in urban and semi-urban areas and rising awareness of respiratory conditions are fostering the demand. Moreover, the improvement of fingertip oximeters by integrating advanced technologies, such as Bluetooth, alarm systems, etc., can further fuel their demand.

End-user Insights

Why Did the Hospital Segment Dominate the Pulse Oximeters Market in 2025?

The hospital segment held the largest share of the market in 2025, due to the rising number of surgical procedures and hospitalizations. Ward expansion, equipment upgrades, and regulatory requirements in hospitals are driving the demand for pulse oximeters. Hospital-grade pulse oximeters can read through perfusing cardiac arrhythmias such as atrial fibrillation and premature atrial or ventricular contractions.

The home healthcare segment is anticipated to grow at the fastest rate during the forecast period, driven by an increasing geriatric population and the growing demand for home healthcare. Telehealth, and patients' growing adoption of it, is also important among home health care industry trends. Home health care provides patients comfort, independence, and familiarity. Patients tend to recover better at home.

Regional Insights

Which Region Dominated the Pulse Oximeters Market?

North America dominated the market in 2025, driven by a rise in the prevalence of respiratory disorders, availability of advanced healthcare facilities in North American countries, and an increase in awareness among patients regarding cost-effective pulse oximeters, which are responsible for the market expansion. AI integration and sophisticated sensors, like Masimo SET, with improved usability. However, the U.S. FDA revealed new draft guidance that recommends extensive clinical performance testing for medical-grade pulse oximeters.

U.S. Pulse Oximeters Market Size and Growth 2026 to 2035

The U.S. pulse oximeters market size was valued at USD 932.96 million in 2025 and is expected to reach USD 2,303.09 million by 2035, growing at a CAGR of 9.46% from 2026 to 2035.

North American region is anticipated to dominate the market with the market share of 49% in 2025. Factors, such as an increase in the prevalence of respiratory disorders, availability of advanced healthcare facilities in North American countries, and growth in awareness among patients regarding cost-effective pulse oximeters are responsible for the market growth.

According to the article published in March 2025, the FDA's 2025 pulse oximetry guidance introduced stricter accuracy standards, larger study cohorts, and objective skin pigmentation assessment to address measurement bias in darker-skinned patients. The FDA's new 2025 draft guidance requires pulse oximeter validation studies to increase participant cohorts from 10 to 150, with at least 25% having dark skin and 30% of data points derived from darker-skinned individuals to reduce measurement bias.

• In 2023, the Behavioral Risk Factor Surveillance System (BRFSS) survey found that approximately 24.4 million (9.9 percent) of adults residing in the United States and 6.9 percent of children from twenty-seven states reported currently having asthma. About 15.4 million adults (6.2 percent) reported ever being diagnosed with COPD.
• According to the CDC data, the Number of visits to emergency departments with COPD as the primary diagnosis is 854,000.

U.S. Pulse Oximeters Market Trends

Demand for pulse oximeters in the U.S. is witnessing sustained growth driven by the increasing prevalence of chronic respiratory diseases such as COPD and asthma, a growing geriatric population requiring continuous health monitoring, and rising adoption of remote patient monitoring solutions. The increasing emphasis on early disease detection and technological advancements in portable monitoring devices.

Asia Pacific Pulse Oximeters Market Trends

The Asia Pacific region is expected to grow at the fastest rate during the forecast period, due to the high occurrence of chronic disease across the region. Moreover, a high population, rising income levels, and enhancement in patient consciousness for cutting-edge pulse oximeters would further upsurge market growth. Government initiatives and healthcare programs in India have aimed at enhancing healthcare infrastructure and accessibility. These efforts often include equipping healthcare facilities with modern medical equipment, including pulse oximeters.

The Asia Pacific region is expected to grow at the fastest growth rate due to the high occurrence of chronic disease across the region. Moreover, a high population, augmented incomes levels, and enhancement in patient consciousness for cutting-edge pulse oximeters would further upsurge market growth. The Middle East & Africa region is projected to show a sizable growth rate during the prediction period.

India Pulse Oximeters Market Trends

The India pulse oximeter demand is expected to experience steady demand, primarily driven by rising health awareness and the incidence of chronic respiratory and cardiac conditions. The market is experiencing innovations like Bluetooth-enabled devices and integration with mobile health apps, which improve user convenience and support wide adoption among tech-savvy consumers.

Europe Pulse Oximeters Market Trends

Europe is a prominent market for pulse oximeters with countries such as Germany, the UK, and France contributing to the overall demand. A growing elderly population susceptible to respiratory ailments, increased adoption of remote patient monitoring platforms, and rising healthcare expenditure are driving the market. To identify the unique needs of pediatric patients, there is growing focus on innovations in pulse oximetry technology specifically designed for children and infants.

Germany Pulse Oximeters Market Trends

In Germany, the market players are actively investing in technological advancements in wearable pulse oximeters, driving significant growth in the pulse oximeter demand. Healthcare professionals increasingly rely on these devices for continuous patient monitoring, which is essential for managing chronic conditions and ensuring timely interventions.

Middle East and Africa Pulse Oximeters Market Trends

The pulse oximeter sector in the Middle East and Asia has experienced considerable growth, fueled by the rising prevalence of chronic respiratory and cardiovascular diseases, heightened health awareness, and improvements in healthcare facilities. In this region, pulse oximeters have gained popularity alongside advancements in healthcare services, particularly in countries like Saudi Arabia, the UAE, and Israel, where there is a strong emphasis on upgrading medical establishments.

UAE Pulse Oximeters Market Trends

The rise of home healthcare and telemedicine has led to increased sales of COVID-19 oximeters, as these devices become more affordable in the UAE. Additionally, many people find that monitoring their lung health helps alleviate anxiety. Abonemed Medical Equipment LLC is recognized as the top pulse oximeter supplier in the UAE, trusted by numerous hospitals, clinics, and laboratories.

Latin America Pulse Oximeters Market Trends

In Latin America, there is a rising prevalence of chronic respiratory issues such as asthma and COPD, alongside an increase in cardiovascular diseases attributed to lifestyle changes. Urbanization is rapidly advancing throughout the continent, with private hospitals and specialized clinics expanding their services in major metropolitan areas. Latin America, particularly Mexico, Brazil, and Argentina, is emerging as a significant market due to growing health awareness and improved healthcare infrastructure.

Brazil Pulse Oximeters Market Trends

Brazil leads the Latin America pulse oximeter sector due to its robust healthcare infrastructure and early adoption of medical technologies. Respiratory diseases are among the top five causes of mortality in Brazil. Technological advancements have produced more accurate, user-friendly, and affordable oximeters, further boosting market growth. Additionally, Brazil's large and aging population increasingly relies on at-home health monitoring tools, creating additional demand.

Competitive Landscape

The competitive landscape of the pulse oximeters market is characterized by an emphasis on technological innovation, integration capabilities, and strategic partnerships. As the market continues to evolve, the focus on user-friendly and efficient solutions is likely to impact product development and industry growth. Top companies in the market are adopting strategies such as new product development, strategic partnerships and collaborations, and geographic expansion to remain competitive and for future growth.

Pulse Oximeters Market Companies

• Smiths Group plc.
• Halmaplc
• Koninklijke Philips N.V.
• Medtronic plc
• Nihon Kohden Corporation
• Masimo Corporation
• Contec Medical Systems Co., Ltd.
• Omron healthcare, Inc.
• General Electric Company
• Nonin Medical, Inc.

Leadership Announcement

• In February 2024, Masimo announced the FDA clearance of MightySat Medical, making it the first and only FDA-cleared medical fingertip pulse oximeter available Over-The-Counter (OTC) direct to consumers without a prescription. This clearance brings consumers a pulse oximeter medical device powered by Masimo SET pulse oximetry—the same technology relied on by hospitals and clinics worldwide to monitor more than 200 million patients annually and shown to have no clinically significant difference in accuracy or bias between individuals with light and dark skin.
• Prevounce Health comes as one of the leading providers of software for remote care management by announcing its first blood oxygen device under the venture of remote patient monitoring (RPM): Pylo OX1-LTE. According to Daniel Tashnek, founder and Chief Executive Officer of Prevounce, this device was an exciting addition to the Pylo family. Even as the device delivers actionable data to clinicians for empowering care, it will be allowed to be used much more easily by patients. This will ensure increased involvement and participation in RPM programs while reducing both clinician and technical support work needed to scale up remote monitoring programs.

Recent Developements

• In October 2024, Tenovi and Nonin Medical Partner announced a strategic partnership to advance health equity through remote patient monitoring for patients with chronic care needs. Research has shown that fingertip pulse oximeters from Nonin performed significantly better than competing models under conditions of dyspnea and low perfusion. The Model 3230 was designed to provide accurate readings for patients of varying skin tones, which is crucial to ensuring patients receive equitable care.
  
• In December 2024, Zynex, Inc., an innovative medical technology company specializing in the manufacture and sale of noninvasive medical devices for pain management, rehabilitation, and patient monitoring, announced its membership as an industry member in the Collaborative Community of the independently led Open Oximetry Project. The project, led by the University of California, San Francisco's Center for Health Equity in Surgery and Anesthesia, is dedicated to improving the safety and accuracy of pulse oximeters in all populations.
• In November 2023, In November 2023, GE HealthCare announced a joint agreement with Masimo. The collaboration aims to integrate Masimo Signal Extraction Technology (SET) pulse oximetry into GE HealthCare's Portrait Mobile wireless and wearable patient monitoring solution. Portrait Mobile is built as an Internet of Medical Things (IoMT) platform, using the latest cloud native technology to provide an end-to-end experience for wearable continuous monitoring. The agreement follows Portrait Mobile's 510(k) clearance from the U.S. FDA in August 2023.
• In February 2024, Masimo announced FDA clearance of MightySat Medical, making it the first and only FDA-cleared medical fingertip pulse oximeter available Over-The-
• In January 2025, the United States Food and Drug Administration released guidelines for manufacturers regarding the calibration of their devices to better read pulse oxygen readings for people of color, by ensuring devices are tested across a variety of skin tones. The new guidelines ask companies to mandate the collection of 3,000 data points rather than 200. Studies conducted using these meters will also need to be composed of a minimum of 10 people, with 150 being the recommended sample size.
• In August 2024, Prevounce Health, a leading medical device provider, launched a remote patient-monitoring blood oxygen measurement device called Pylo OX1-LTE. The device is cellular connected, offering secure data collection, reliability and improved connectivity. The device is cost-effective, making it easier for organizations to invest in growing their remote patient monitoring programs.

Segments Covered in the Report

By Product Type

• Handheld Oximeters
• Fingertip Oximeters
• TabletopOximeters

By End-user

• Ambulatory Surgical Centers
• Hospitals
• Home Healthcares

By Region

• North America
• Latin America
• Europe
• Asia-pacific
• Middle and East Africa